These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 12557752)
1. Beta 2 microglobulin serum levels and prediction of survival in AL amyloidosis. Zerbini CA; Anderson JJ; Kane KA; Ju ST; Campistol JM; Simms RW; Cohen AS; Skinner M Amyloid; 2002 Dec; 9(4):242-6. PubMed ID: 12557752 [TBL] [Abstract][Full Text] [Related]
6. Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis. Spiegel DM; Sprague SM Am J Kidney Dis; 1992 May; 19(5):427-32. PubMed ID: 1585929 [TBL] [Abstract][Full Text] [Related]
7. Beta 2-microglobulin levels in patients with renal insufficiency. Acchiardo S; Kraus AP; Jennings BR Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313 [TBL] [Abstract][Full Text] [Related]
8. Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. Greipp PR; Katzmann JA; O'Fallon WM; Kyle RA Blood; 1988 Jul; 72(1):219-23. PubMed ID: 3291982 [TBL] [Abstract][Full Text] [Related]
9. Long-term clinical evaluation of an adsorbent column (BM-01) of direct hemoperfusion type for beta 2-microglobulin on the treatment of dialysis-related amyloidosis. Gejyo F; Teramura T; Ei I; Arakawa M; Nakazawa R; Azuma N; Suzuki M; Furuyoshi S; Nankou T; Takata S Artif Organs; 1995 Dec; 19(12):1222-6. PubMed ID: 8967878 [TBL] [Abstract][Full Text] [Related]
10. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Jadoul M; Garbar C; Noël H; Sennesael J; Vanholder R; Bernaert P; Rorive G; Hanique G; van Ypersele de Strihou C Kidney Int; 1997 Jun; 51(6):1928-32. PubMed ID: 9186884 [TBL] [Abstract][Full Text] [Related]
11. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis. Garbar C; Jadoul M; Noël H; van Ypersele de Strihou C Kidney Int; 1999 May; 55(5):1983-90. PubMed ID: 10231463 [TBL] [Abstract][Full Text] [Related]
12. C1Q complexes with beta-2-microglobulin and amyloid P-component in sera of patients with dialysis-associated amyloidosis. Hasegawa M; Kawashima S; Shikano M; Kojima K; Yanai T; Hassegawa H; Tomita M; Murakami K; Kawamura N; Katsumata H Nephron; 1995; 69(4):380-3. PubMed ID: 7777100 [TBL] [Abstract][Full Text] [Related]
13. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis? Tielemans C; Dratwa M; Bergmann P; Goldman M; Flamion B; Collart F; Wens R Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia. Kantarjian HM; Smith T; Estey E; Polyzos A; O'Brien S; Pierce S; Beran M; Feldman E; Keating MJ Am J Med; 1992 Dec; 93(6):599-604. PubMed ID: 1466355 [TBL] [Abstract][Full Text] [Related]
19. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma. Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215 [TBL] [Abstract][Full Text] [Related]
20. Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis. Niwa T; Katsuzaki T; Miyazaki S; Momoi T; Akiba T; Miyazaki T; Nokura K; Hayase F; Tatemichi N; Takei Y Kidney Int; 1997 Jan; 51(1):187-94. PubMed ID: 8995733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]